Skip to main content

Most Recent Content

The Bigger Picture: An Expert Assessment on the True Impact of ATTR-CM
  • 1.00 EBAC

Learning objectives

  • Recall the most recent epidemiological data on ATTR-CM incidence and diagnostic trends
  • List red flags indicating the presence of ATTR amyloidosis
  • Identify patients who should undergo detailed diagnosis work-up or referral
  • List the advantages of emerging classes of agents being evaluated in ATTR-CM
See more
AF Stroke Prevention – Applying New Guidance in the Real World
  • 1.00 EBAC

Learning objectives

  • Recall the risk of ischaemic stroke in AF patients
  • Compare therapeutic efficacy and risk between left atrial appendage closure and oral anticoagulation in atrial fibrillation
  • Review European guideline updates on the use of left atrial appendage closure in atrial fibrillation
  • Summarise the clinical evidence behind non-pharmacological approaches to stroke prevention in atrial fibrillation
See more
Cardiac Amyloidosis: Emerging Diagnostic and Treatment Approaches
  • 1.00 EBAC

Learning objectives

  • Understand the nature of amyloidosis and its effects on various organs, particularly the heart
  • Distinguish between light-chain (AL) amyloidosis, wild type TTR amyloidosis and hereditary TTR amyloidosis in terms of their clinical manifestations and their different treatments
  • Recognise the novel challenges of managing heart failure in cardiac amyloidosis, including both medical management and the role of devices
  • Understand the critically important interaction between haematologists and cardiologists in the therapy of AL amyloidosis
  • Develop an understanding of novel therapies currently in clinical trials of TTR and AL amyloidosis
  • Identify their own roles and responsibilities in the management TTR and AL amyloidosis as part of a multidisciplinary team
See more
Advancing Patient Care in Hypertrophic Cardiomyopathy
  • 0.50 AMA PRA Credit

Learning objectives

  • Recall recent trial data for novel disease modifying therapy in HCM
  • Describe the evolving guideline directed approach to managing HCM
  • Develop an expert-led approach to implementing novel therapy in clinical practice
See more
Challenges in ATTR Amyloidosis: An Expert Debate
  • 1.00 EBAC

Learning objectives

  • Comprehend the unique challenges posed to cardiologists who encounter patients with ATTR amyloidosis
  • Initiate first steps in diagnosis of suspect individuals in accordance to latest guidance
  • Have enhanced awareness of the disease trajectory of patients with a mixed ATTR phenotype
  • Recall the limitations of existing therapies for ATTR-CM
  • List the advantages of emerging classes of agents being evaluated in ATTR-CM
See more
A Race Against Time: Accelerating the Adoption of GDMT in Heart Failure
  • Not accredited

Learning objectives

  • Recall guideline recommendations for the use of NT-proBNP in heart failure
  • Describe current practices in heart failure diagnosis and the impact on treatment outcomes
  • Develop an optimised approach to the timely diagnosis and management of heart failure
See more
Advanced Approaches to Combined Epicardial and Endocardial Strategies – From New Consensus to Practice
  • 1.00 EBAC

Learning objectives

  • Identify patient populations who may benefit from hybrid ablation
  • Summarise the existing rationale and evidence for hybrid ablation beyond atrial fibrillation
  • Understand how to integrate left atrial appendage exclusion in atrial ablation approaches
  • Examine key aspects of new consensus recommendations for hybrid ablation
See more
TAVI Head-To-Head: Design, Data and Directions for Clinical Practice
  • 1.00 EBAC

Learning objectives

  • Recall TAVI SMART trial data and the implications on clinical practice
  • Describe novel valve designs and the impact on long-term performance
  • Develop an expert-led approach to improving equitable access to TAVI
See more
TAVI – Is Lifetime Patient Management the Alpha to Omega of Contemporary Practice?
  • 1.00 EBAC

Learning objectives

  • Evaluate the factors influencing coronary access in different valve designs
  • Formulate strategies to optimise coronary access based on valve characteristics
  • Evaluate the role of valve design in reducing pacemaker implantation rates and enhancing future coronary access
  • Learn the step-by-step process for achieving optimum implant depth during TAVI
  • Apply guidelines and best practices for achieving and confirming optimum implant depth in TAVI procedures
See more